These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7195231)

  • 21. Effects of AR-L 115 BS on arterial and venous muscle tone in vitro.
    Nguyen DH; Rüdel R; Voss U
    Arzneimittelforschung; 1981; 31(1a):197-9. PubMed ID: 7195220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
    Pozenel H
    Arzneimittelforschung; 1981; 31(1a):263-6. PubMed ID: 7195238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA; Punzi CF
    J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
    Roth W; Zimmer A; Busch U
    Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experiments with AR-L 115 BS on skinned cardiac fibers.
    Trube G; Trautwein W
    Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
    Micieli G; Martignoni E; Cavallini A; Pacchetti C; Rossi F; Horowski R; Nappi G
    Funct Neurol; 1996; 11(6):317-25. PubMed ID: 9074912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of mianserin--a comparative study with amitriptyline and a placebo in healthy subjects.
    Kopera H; Fluch N; Harpf H; Klein WW; Stulemeijer SM
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):104-9. PubMed ID: 7380584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M; Ibsen H; Worck R
    Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
    Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H
    Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS.
    Kutter E; Austel V
    Arzneimittelforschung; 1981; 31(1a):135-41. PubMed ID: 7195206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium transport in sarcoplasmic reticulum in the presence of AR-L 115 BS].
    Hasselbach W
    Arzneimittelforschung; 1981; 31(1a):191-3. PubMed ID: 7195219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
    Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
    J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI--Europe Research Group.
    Anesthesiology; 1997 Feb; 86(2):346-63. PubMed ID: 9054253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
    Blair JE; Macarie C; Ruzyllo W; Bacchieri A; Valentini G; Bianchetti M; Pang PS; Harinstein ME; Sabbah HN; Filippatos GS; Gheorghiade M;
    Am J Ther; 2008; 15(3):231-40. PubMed ID: 18496261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure and heart rate response of panic disorder patients receiving imipramine in a dose-response treatment paradigm.
    de Groot CM; Mavissakalian MR
    J Clin Psychopharmacol; 1994 Apr; 14(2):107-10. PubMed ID: 8195450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
    Klein G; Sauer E; Bauer R; Wirtzfeld A; Sebening H
    Arzneimittelforschung; 1981; 31(1a):257-9. PubMed ID: 7195236
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemodynamic effects of reboxetine in healthy male volunteers.
    Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
    Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
    Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
    J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.